108 related articles for article (PubMed ID: 25802104)
1. [Comparison of four treatment options for low-risk prostate cancer: Preference-based randomized study for the evaluation of four treatment modalities in prostate cancer with low or "early intermediate" risk (PREFERE) - trial AP 65/11 of the AUO].
Rexer H; Bussar-Maatz R
Urologe A; 2015 May; 54(5):723-5. PubMed ID: 25802104
[No Abstract] [Full Text] [Related]
2. [Clarification regarding criticism on PREFERE].
Stöckle M
Urologe A; 2015 Dec; 54(12):1792-4. PubMed ID: 26704281
[No Abstract] [Full Text] [Related]
3. [PREFERE - Study on the rise].
Ohlmann CH; Stöckle M; Albers P; Schmidberger H; Härter M; Kristiansen G; Martus P; Wellek S; Bussar-Maatz R; Wiegel T
Urologe A; 2016 Mar; 55(3):313-7. PubMed ID: 26908120
[TBL] [Abstract][Full Text] [Related]
4. [Development of patient education materials for the "German Prostate Cancer Trial PREFERE"].
Sänger S; Wiegel T; Stöckle M; Härter M; Bergelt C
Z Evid Fortbild Qual Gesundhwes; 2015; 109(1):28-39. PubMed ID: 25839363
[TBL] [Abstract][Full Text] [Related]
5. [Metastatic, hormone-naive prostate cancer interventional study : Multicenter, prospective, randomized study to evaluate the effect of standard drug therapy with or without radical prostatectomy in patients with limited bone metastasized prostate cancer (G-RAMPP - the AUO AP 75/13 study)].
Rexer H
Urologe A; 2015 Nov; 54(11):1613-6. PubMed ID: 26573673
[No Abstract] [Full Text] [Related]
6. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.
van Tol-Geerdink JJ; Willem Leer J; Weijerman PC; van Oort IM; Vergunst H; van Lin EN; Alfred Witjes J; Stalmeier PF
BJU Int; 2013 Apr; 111(4):564-73. PubMed ID: 22882966
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer.
Kotecha R; Yamada Y; Pei X; Kollmeier MA; Cox B; Cohen GN; Zaider M; Zelefsky MJ
Brachytherapy; 2013; 12(1):44-9. PubMed ID: 22831750
[TBL] [Abstract][Full Text] [Related]
8. Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: a comparison of Australian series.
Wilcox SW; Aherne NJ; McLachlan CS; McKay MJ; Last AJ; Shakespeare TP
J Med Imaging Radiat Oncol; 2015 Feb; 59(1):125-33. PubMed ID: 25588566
[TBL] [Abstract][Full Text] [Related]
9. Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer.
Fletcher SG; Mills SE; Smolkin ME; Theodorescu D
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1092-9. PubMed ID: 16965872
[TBL] [Abstract][Full Text] [Related]
10. [PREFERE--the German prostatic cancer study].
Porzsolt F
Urologe A; 2014 Mar; 53(3):388-9. PubMed ID: 23975217
[No Abstract] [Full Text] [Related]
11. [PREFERE--the German prostatic cancer study].
Weißbach L; Theuerkauf O
Urologe A; 2014 Mar; 53(3):387. PubMed ID: 23975216
[No Abstract] [Full Text] [Related]
12. [PREFERE - the German prostatic cancer study: questions and claims surrounding study initiation in January 2013].
Wiegel T; Albers P; Bussar-Maatz R; Gottberg A; Härter M; Kieser M; Kristiansen G; Nettekoven G; Martus P; Schmidberger H; Wellek S; Stöckle M
Urologe A; 2013 Apr; 52(4):576-9. PubMed ID: 23571802
[TBL] [Abstract][Full Text] [Related]
13. Changes in prognostic and therapeutic parameters in prostate cancer from an epidemiological view over 20 years.
Dörr M; Hölzel D; Schubert-Fritschle G; Engel J; Schlesinger-Raab A
Oncol Res Treat; 2015; 38(1-2):8-14. PubMed ID: 25633491
[TBL] [Abstract][Full Text] [Related]
14. Gleason score 7 prostate cancer treated with interstitial brachytherapy with or without supplemental external beam radiation and androgen deprivation therapy: is the primary pattern on needle biopsy prognostic?
Bittner N; Merrick GS; Butler WM; Galbreath RW; Adamovich E; Wallner KE
Brachytherapy; 2013; 12(1):14-8. PubMed ID: 22884256
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant radiotherapy in lymph-node-positive prostate cancer with low tumor burden after radical prostatectomy : Multicenter randomized phase III trial on the effect of adjuvant radio therapy in patients with prostate cancer with or without positive margins after radical prostatectomy (RP) and lymph node metastasis with low tumor burden (micrometastases, ≤ 2 lymph node macrometastases). ART-2 trial AP 61/11 of the AUO].
Rexer H; Bartkowiak D
Urologe A; 2015 Jun; 54(6):871-4. PubMed ID: 26081820
[No Abstract] [Full Text] [Related]
16. Treatment of localised prostate cancer: inform patients about adverse effects.
Prescrire Int; 2012 Oct; 21(131):247. PubMed ID: 23185851
[No Abstract] [Full Text] [Related]
17. A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006.
Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Rigatti P; Montorsi F; Karakiewicz PI
Eur Urol; 2011 Jan; 59(1):88-95. PubMed ID: 20965646
[TBL] [Abstract][Full Text] [Related]
18. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
19. [PREFERE--open questions].
Schäfer C; Weißbach L
Urologe A; 2014 Mar; 53(3):384-6. PubMed ID: 24510130
[No Abstract] [Full Text] [Related]
20. Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.
Zelefsky MJ; Pei X; Teslova T; Kuk D; Magsanoc JM; Kollmeier M; Cox B; Zhang Z
BJU Int; 2012 Dec; 110(11):1696-701. PubMed ID: 22889401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
